All the
information about Pfizer Stop Smoking Pill Chantix
Pfizer? Initiative:-
Chantix is the latest prescription medicine
developed and marketed by Pfizer that help quit
smoking. The medicine has recently been approved
by the US Food and drug Administration. This latest
addition to the age old malady of smoking that is
considered as the single most preventable causes of
death in the country is found to be more effective
than other drugs available for cessation of smoking.
In spite of registering a reduction of 21 percent in
the smokers in the United States the country ha
still about 45 million smoking population with a
total consumption of 388 billion cigarettes per
year. Chantix is not the first medicine of its kind
used in cessation of smoking. Zyban marketed by
Glaxo is its predecessor but the former is claimed
to be more effective than the latter. This discovery
of Pfizer and the fourth new medicine of the firm to
get approval from FDA in the year 2006 are
considered as a breakthrough in the treatment for
smoking.
The Breakthrough!
The discovery and development of Chantix by the
Pfizer is a break through in the development of an
effective medicine that help reduce the craving for
smoking and finally lead to the to the first
prescription treatment for habitual smoking
cessation in nearly a decade. The discovery of
Chantix is a living testimony of Pfizer's focus and
commitment to help combat the avoidable human and
economic cost of this disease through effective
prevention by their scientific innovation and large
scale patient support initiatives. It is expected
that the medicine would help reduce smoking in
adults at faster pace in the coming days. It is well
known that majority of habitual smokers wants to
quit smoking but is incapable to do so due to the
strong urge and crave for nicotine. It is this
feature of the nicotine that is offset by the
chantix.
|
